The pan PI3K inhibitor SAR245408 demonstrated cytotoxic activity in a panel of pediatric tumor cell lines, including sarcomas, with a median relative IC50 of 10.9 μM [28]. This evidence concerns the gene PIK3CA and neoplasm.